Se-cure is a clinical stage & revenues generating, research-driven pharmaceutical company, which has developed a proprietary platform for the discovery, development and scaling of therapies from botanical origin. Founded in 1997, Se-cure processes natural complex of biochemical compounds as found in the original plant, as a basis for designing therapies which selectively target specific tissues, while leaving other tissues intact.
Implementing proprietary botanical drug development and scaling technologies, Se-cure  introduces novel biochemical agents characterized by functionally selective mechanisms of action in the target tissues providing safe and effective solutions to medical needs.

Brizo™ for benign prostatic hyperplasia (BPH) is being launched in Norway in October 2011

Home   |   About   |   R&D   |   Pipeline   |   Media   |   Investors   |   Contact